Showing results (281-290 of 372) with videos related to
Sort By:
Pageof 38
The Cancer Journal From Scientific American|December 24, 1997
TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanomaE C Hsueh, R K Gupta, K Qi, et al.Indian Journal of Experimental Biology|February 24, 2001
Immunology of gangliosidesM H Ravindranath, A M Gonzales, K Nishimoto, et al.Biochemistry International|July 1, 1992
Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activityD S Hoon, M M Kaback, J Lim-Steele, et al.Anticancer Research|May 6, 1998
Glucosylceramide: a marker for multiple-drug resistant cancersA Lucci, W I Cho, T Y Han, et al.The Cancer Journal From Scientific American|December 22, 1999
Radiofrequency ablation: a minimally invasive technique with multiple applicationsA J Bilchik, D M Rose, D P Allegra, et al.Journal of the National Cancer Institute|January 1, 1976
Comparison of histocompatibility antigens on cultured human tumor cells and fibroblasts by quantitative antibody absorption and sensitivity to cell-mediated cytotoxicityS H Golub, D C Hanson, H L Sulit, et al.Medical and Pediatric Oncology|January 1, 1976
High dose methotrexate therapy of solid tumors: observations relating to clinical toxicityW H Isacoff, C M Townsend, F R Eiber, et al.Cancer|August 1, 1993
A preclinical model to assess the antigenicity of an HLA-A2 melanoma cell vaccineY Hayashi, D S Hoon, L J Foshag, et al.Cancer|July 1, 1985
Phase I trial of thermochemotherapy for brain malignancyA W Silberman, R W Rand, F K Storm, et al.Cellular Immunology|February 1, 1992
Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-AY Hayashi, D S Hoon, M S Park, et al.Pageof 38